| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2009 | WO2009011967A1 Oral pharmaceutical dosage form and manufacturing method thereof |
| 01/22/2009 | WO2009011938A1 Bioabsorbable elastomeric arterial support device and methods of use |
| 01/22/2009 | WO2009011924A1 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 01/22/2009 | WO2009011912A1 A composition for treating hiv comprising virus-like particles |
| 01/22/2009 | WO2009011910A2 Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment |
| 01/22/2009 | WO2009011904A1 Compounds useful as faah modulators and uses thereof |
| 01/22/2009 | WO2009011901A2 Methods for promoting wakefulness |
| 01/22/2009 | WO2009011893A2 Treatments of b-cell proliferative disorders |
| 01/22/2009 | WO2009011889A2 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/22/2009 | WO2009011880A2 Heterocyclic modulators of pkb |
| 01/22/2009 | WO2009011876A1 Method and apparatus for steam hydro-gasification with increased conversion times |
| 01/22/2009 | WO2009011872A1 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 01/22/2009 | WO2009011871A2 Thiadiazole modulators of pkb |
| 01/22/2009 | WO2009011870A1 Reduction of beta-amyloid levels by treatment with the small molecule differentiation-inducing factor |
| 01/22/2009 | WO2009011851A1 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 01/22/2009 | WO2009011850A2 Novel therapeutic compounds |
| 01/22/2009 | WO2009011836A1 Beta carboline derivatives as antidiabetic compounds |
| 01/22/2009 | WO2009011795A2 Methods for treating stress induced emotional disorders |
| 01/22/2009 | WO2009011787A1 Anti-viral compounds, compositions, and methods of use |
| 01/22/2009 | WO2009011775A1 Amidoethyl alkylamino orexin receptor antagonists |
| 01/22/2009 | WO2009011705A1 Enhanced formulations of lamotrigine |
| 01/22/2009 | WO2009011702A1 Self-assembling amphiphilic polymers as anticancer agents |
| 01/22/2009 | WO2009011655A1 Splropiperidine compounds, a process of their preparation, pharmaceutical compositions containing them, and their use in the treatment of airway diseases, inflammatory diseases, copd or asthma |
| 01/22/2009 | WO2009011653A1 A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds |
| 01/22/2009 | WO2009011627A1 Pyridine compounds and their use as p2y12 antagonists |
| 01/22/2009 | WO2009011617A2 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 01/22/2009 | WO2009011576A1 Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation |
| 01/22/2009 | WO2009011567A1 Crystalline forms of efavirenz |
| 01/22/2009 | WO2009011561A1 Pharmaceutical composition combining lamotrigine and clonazepam, and use thereof for treating convulsive disorders and epileptic syndromes |
| 01/22/2009 | WO2009011560A1 Pharmaceutical composition combining risperidone and donepezil, and use thereof for treating psychotic disorders such as schizophrenia and dimentias such as alzheimer's disease |
| 01/22/2009 | WO2009011451A1 Solid preparation comprising alogliptin and metformin hydrochloride |
| 01/22/2009 | WO2009011449A2 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 01/22/2009 | WO2009011420A1 Therapeutic agent for type-2 diabetes |
| 01/22/2009 | WO2009011412A2 Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain |
| 01/22/2009 | WO2009011411A1 Ampa receptor antagonists and zonisamide for neuropathic pain |
| 01/22/2009 | WO2009011410A1 Ampa receptor antagonists and aldose reductase inhibitors for neuropathic pain |
| 01/22/2009 | WO2009011336A1 Quinoline compounds |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009011276A1 Zinc salt of isothiazolone compound, method of reducing stimulus of isothiazolone compound, antibacterial/antifungal method employing zinc salt of isothiazolone compound, and antibacterial/antifungal composition |
| 01/22/2009 | WO2009011112A1 Stable fat emulsion containing prostaglandin e1 |
| 01/22/2009 | WO2009010988A1 An improved, industrially viable process for the preparation of high purity paliperidone |
| 01/22/2009 | WO2009010987A1 An improved process for the preparation of pure palonosetron hydrochloride |
| 01/22/2009 | WO2009010986A1 Topical cream compositions of sertaconazole nitrate |
| 01/22/2009 | WO2009010974A2 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 01/22/2009 | WO2009010967A1 An agent for treatment of inflammation |
| 01/22/2009 | WO2009010871A2 Pyrazole derivatives as antagonists of adenosine a3 receptor |
| 01/22/2009 | WO2009010824A1 Dihydrochromenopyrazole derivatives as vanilloid receptor ligands |
| 01/22/2009 | WO2009010810A2 Cardiovascular combinations comprising ace and hmg-co-a inhibitors |
| 01/22/2009 | WO2009010804A1 Macrocyclic compounds as antiviral agents |
| 01/22/2009 | WO2009010801A1 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 01/22/2009 | WO2009010794A1 2,4-diamino-pyrimidine derivatives |
| 01/22/2009 | WO2009010791A2 Cyclic ethers |
| 01/22/2009 | WO2009010787A2 Stable pharmaceutical compositions comprising one or more hmg-coa reductase inhibitors |
| 01/22/2009 | WO2009010785A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 01/22/2009 | WO2009010784A1 New compounds 955 |
| 01/22/2009 | WO2009010783A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 01/22/2009 | WO2009010770A2 Dry-powder medicament |
| 01/22/2009 | WO2009010761A1 Dna pk inhibitors |
| 01/22/2009 | WO2009010707A1 Injectable pharmaceutical compositions containing panthenol |
| 01/22/2009 | WO2009010687A2 Target enzyme in the treatment of acne |
| 01/22/2009 | WO2009010660A2 Substituted indazoles, the preparation thereof, and use of same in therapeutics |
| 01/22/2009 | WO2009010560A1 Pyrazole derivatives and use thereof as inhibitors of stearoyl-coa desaturase |
| 01/22/2009 | WO2009010555A1 New drugs with anticholestatic activity |
| 01/22/2009 | WO2009010542A1 Cyclic amide compounds, method for the production thereof and the use thereof |
| 01/22/2009 | WO2009010531A1 Novel one step process for preparing cross-linked poly(allylamine) polymers |
| 01/22/2009 | WO2009010530A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/22/2009 | WO2009010529A1 Synergistic combinations of vr-1 antagonists and cox-2 inhibitors |
| 01/22/2009 | WO2009010492A2 Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as copd or asthma |
| 01/22/2009 | WO2009010491A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | WO2009010488A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | WO2009010480A1 1-{2-[(diphenyl)amino]-ethyl}-piperidine-4-carboxylic acid benzylamide derivatives and related compounds as ccr5 agonists for the treatment of immune and inflammatory diseases |
| 01/22/2009 | WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use |
| 01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 01/22/2009 | WO2009010477A1 Piperidine-4-acetic acid derivatives and their use |
| 01/22/2009 | WO2009010455A2 Pyrazole derivatives as modulators of metabotropic glutamate receptors |
| 01/22/2009 | WO2009010454A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/22/2009 | WO2009010448A2 Anti-inflammatory dermatological composition comprising corticosteroids and hyaluronate fragments, and uses thereof |
| 01/22/2009 | WO2009010429A2 Novel heterocyclyl compounds and their use as chemokine antagonists |
| 01/22/2009 | WO2009010416A2 Inhibitors of 11b-hydroxysteroid dehydrogenase |
| 01/22/2009 | WO2009010299A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/22/2009 | WO2009010296A2 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 01/22/2009 | WO2009010238A2 Duloxetine formulations |
| 01/22/2009 | WO2009010163A1 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections |
| 01/22/2009 | WO2009010021A1 Immunostimulatory activity of trilobolide and method of preparation thereof |
| 01/22/2009 | WO2009009951A1 2'-fluoro-4'-substituted nucleosides, the preparation and use |
| 01/22/2009 | WO2009009907A1 Use of vasopressin-receptor agonists for the treatment of septic shock |
| 01/22/2009 | WO2009009829A1 Method for reducing intracranial pressure |
| 01/22/2009 | WO2009009813A1 Organic compounds |
| 01/22/2009 | WO2009009812A1 Pleuromutilin derivatives and their use as antimicrobials |
| 01/22/2009 | WO2008147474A3 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 01/22/2009 | WO2008147169A3 Microemulsion containing pirfenidone |
| 01/22/2009 | WO2008145842A3 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/22/2009 | WO2008144346A3 Crystal structures of sglt2 inhibitors and processes for their preparation |
| 01/22/2009 | WO2008144241A3 Altering pharmacokinetics of pirfenidone therapy |
| 01/22/2009 | WO2008143906A3 Hypercompressed particles for controlled release of ophthalmic medications |
| 01/22/2009 | WO2008143876A3 Agents and assays for modulating neurodegeneration |
| 01/22/2009 | WO2008143500A4 Tenofovir disoproxil hemi-fumaric acid co-crystal |
| 01/22/2009 | WO2008142550A3 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 01/22/2009 | WO2008138754A3 New solid forms of fxa inhibitors |
| 01/22/2009 | WO2008137809A3 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof |